chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Next day severe heat, swelling and pain at site. 2nd day severe heat, swelling and pain of entire upper arm 3rd day difficulty breathing, wheezing 4th day spasmodic coughing 5 - 12 day continued pneumonia like symptoms PLEASE NOTE: I HAD PNEUMONIA IN BOTH LUNGS AND WAS HOSPITALIZED FOR FIVE DAYS IN JUNE 2017. I HAD EMBOLISMS IN BOTH LUNGS, FLUID ON THE LUNGS, AND WAS ON OXYGEN FOR ABOUT 6 MONTHS, DAILY INITIALLY AND OCCASIONALLY AFTER 4 MONTHS. Treatment: I could not reach my physician despite repeated attempts. My pulmonologist had previously prescribed a protocol of prednisone and a z-pack should those symptoms recur. Day 6 after vaccine I began the protocol. Day 10 saw improvement in breathing and coughing. Day 14 symptoms resolved. Day 14 (Feb. 16) to Present (March 3) no unusual symptoms. Some nasal congestion and mild occasional wheezing, consistent with pollen season and my usual COPD symptoms. Thank you.
pt recv vax 10FEB96 & 18JUN96 pt was exposed to an adult who had full blown chickenpox;18JUN pt erupted w/about 14 lesions & devel a fever;pt seen by MD 22JUN96 w/30-40 lesions on the trunk, face & thigh;dx w/chickenpox;pt recovered;
p/ pt recv vax pt exp varicella-like rash w/less than 20 vesicles. md attention sought
Patient fainted.  Patient did not eat before vaccine appointment and reported being nervous. Patient did not get injured and was able to leave without medical assistance. Patient remained in pharmacy for about 30 minutes after fainting to recover.
This is the first time I have ever had a reaction to a vaccination.  The evening of vaccination:  I was very tired by 8:00 PM and went to bed.  The next day I had no energy, no appetite, and was cold all day.  A themerature check that evening registered 100.2.  I took two 500 mg Tylenol and went to bed.  Next day, I felt fine.  All symptoms had resolved.
03.24.2021 New onset of injection site tenderness 03.25.2021 Red, slightly itchy rash developed around injection site
I have metal in my right shoulder, whole right arm went numb for half a day and was week. Metal in my left foot, whole left let=g is swollen and hurts, saw 3 doctors and they didn't know what to do, one doctor gave me Ibuprofen
It was hard for her to breathe for a day; Her arm around her injection site she started to get a burning sensation; A spontaneous report was received from a consumer concerning a female patient  of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced burning sensation on injection site and breathing difficulty.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, a week prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On unknown date, a week after receiving the mRNA-1273 vaccine, the patient started to get burning sensation around the injection site, which was on and off for two weeks. On unknown date two weeks after the vaccine she reported that it was hard to breathe for a day.   She had since realized that she was allergic to two of the ingredients in the vaccine.   No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of burning sensation on injection site was recovered and breathing difficulty was unknown.; Reporter's Comments: Very limited information regarding these events has been provided at this time. Patient indicated was allergic to two of the ingredients in the vaccine. Further information has been requested.
Swollen area 4 inches x 12 inches down the back of the arm. Red, Swollen, inflamed and pruritic.
Most of left arm - Deltoid - red, hot to touch, large knot under skin. Treated with Kenalog 20mg IM and Prednisone taper for 3 days.
No adverse event; Inadvertently grabbed the underage Moderna 6 months to 5 years and administered 0.5 ml of that to 5 adults instead of giving the bivalent to adults; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Inadvertently grabbed the underage Moderna 6 months to 5 years and administered 0.5 ml of that to 5 adults instead of giving the bivalent to adults) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 21-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Inadvertently grabbed the underage Moderna 6 months to 5 years and administered 0.5 ml of that to 5 adults instead of giving the bivalent to adults). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Inadvertently grabbed the underage Moderna 6 months to 5 years and administered 0.5 ml of that to 5 adults instead of giving the bivalent to adults) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Inadvertently grabbed the underage Moderna 6 months to 5 years and administered 0.5 ml of that to 5 adults instead of giving the bivalent to adults).    No concomitant drug was reported. No treatment drug was reported. This case contains information for the 5th of 5 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-650483, US-MODERNATX, INC.-MOD-2022-650478, US-MODERNATX, INC.-MOD-2022-650481, US-MODERNATX, INC.-MOD-2022-650482 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-650483:patient 4 US-MODERNATX, INC.-MOD-2022-650478:patient 1 US-MODERNATX, INC.-MOD-2022-650481:patient 2 US-MODERNATX, INC.-MOD-2022-650482:patient 3
From initial information received on 28Mar05 from a health care professional regarding an adverse event, it was reported that a 44 year old male pt received a dose of IPOL, lot number W07042, administered IM in the left deltoid on 11Mar05. One day later, on 12Mar05, the pt developed fatigue. He had previously received a dose of Twinrix, lot number AHABA015AA, admin IM in the left deltoid on 03Mar05. He has not recovered from this event. The pt had another adverse event following subsequent vaccination. The information for this event is captured in case 200500663.
I got very dizzy about 12 hrs after receiving both doses and also had heavy spotting two days after receiving the second dose of the vaccine. This is abnormal for me and I never spot between cycles. I was in the middle of my cycle and was not anticipating any bleeding. The spotting stopped after around 3 days. After a few weeks I started to receive hives all over my body and am still having urticaria. I spoke with a dermatologist who recommended I submit this form given there is a chance I am having urticaria from the vaccine as that is the only change I made in my life that may have caused the hives. I had covid in November of 2020, and received the second dose of the vaccine in early May. The dermatologist mentioned I may be having a strong autoimmune response as a result of already having covid and taking the vaccine closely after, although it is hard to know if it caused it and may be unrelated. I am taking regular medication (antihistamines, and just started a new regimen of meds) to try to treat it. I have been having hives every day since
I got shingles/and I ha had shingles shots/ Suspect vaccination failure; I got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID 19 VACCINE for prophylaxis.   On an unknown date, the patient received Shingles vaccine and the 1st dose of COVID 19 VACCINE. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient. The age at vaccination was not reported. The age group was not reported but selected as adult as per the vaccine indication. The patient got shingles after 1st dose of Covid vaccine and also he or she had received the Shingles shots. The patient stated that, he or she would not take the 2nd dose of Covid. It was unknown if the reporter considered the shingles to be related to Covid vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Patient rc'd DTAP vaccine #5 the next day left arm was swollen & red .She had full use of her arm. Next day mom called & said arm was more reddened & she took child to M. D. & he prescribed antibiotics for 10 days .
swelling on arm; itchy red ring around the circumference of her arm; Based on additional information received on 25-Oct-2019, this case initially considered as non-Case was upgraded to valid case.   Initial information received on 25-Oct-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves unknown demographic patient who experienced swelling on arm (peripheral swelling) and itchy red ring around the circumference of her arm (rash), while received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot QFAA1933 (Expiry date unknown) via intramuscular route in unknown administration site.  On an unknown date, the patient developed a non-serious swelling on arm (peripheral swelling) and itchy red ring around the circumference of her arm (rash) (Unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was Local swelling and Localised rash.  It was not reported if the patient received a corrective treatment.  The event outcome is reported as Unknown for Rash over arms and Swelling arm.
p/vax pt devel a severe case of chickenpox w/greater than 100 lesions from which subsequently recovered;
Injection site red, hot to touch, swollen: right leg around 8x8 cm.
patient was given vaccine and walked out of room. as i was in the room vaccinating sibling i could hear mom saying sit down when i came out patient appeared to be passing out. mom was handling situation i proceeded to call for 911 but mom said no i offered to lie her down and got orange juice a few seconds later mom says she is going down again and maybe call 911 she states patient seems to be seizing up asked if she ever had seizure she said no. patient in and out talking mom gave her ice for neck another customer who was a trained nurse stood by to  assist patient left in ambulance
10/17/2006 Had Dtap LA, 10/19/06 LA swollen, red, blisters, tender touch at injection site. Area about 5" diameter. Tylenol, compresses RX come in if not better, child has had no fever.
28 year old physical therapist dead after moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (28 year old physical therapist dead after moderna vaccine) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on an unknown date It is unknown if an autopsy was performed.            Treatment and concomitant drug details not reported.
nausea; headache; body aches; 99.4 F fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches) and PYREXIA (99.4 F fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included INTERFERON BETA-1A (AVONEX) for an unknown indication.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches) and PYREXIA (99.4 F fever). At the time of the report, NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches) and PYREXIA (99.4 F fever) outcome was unknown. Not Provided    No treatment information was provided.
2 weeks after received 1st COVID vaccine patient began having fatigue and dizziness; also having issues with elevated blood pressure; patient states she will not get the 2nd dose of the vaccine
Patient complained of tingling in head, lightheaded and dizzy with a rapid heart rate.  EMS on site for event, patient seen and released.  Patient continued on site for an additional 30 minutes before heading home.  Patient stated she feels better, closer to baseline but not completely normal.  Referred her to sign up for v-safe and call 911 or go to the nearest emergency room if she has any further issues,
The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). On 15-Apr-2021, PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.
Patient is age 17 received a booster dose of Pfizer. Patient is not immunocompromised. Patient called and mother notified. no adverse event occurred with patient.
Information has been received from a Licensed Practical Nurse (L.P.N.) referring to multiple unspecified patients of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On multiple unspecified dates, the patients were vaccinated with improperly stored VAQTA adult formation 50 U/1.0 ml (dose, lot # and route unspecified). Information regarding medications was not reported. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Headache in front of head; A metallic taste within 10 minutes of the injection; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Mar2021 12:30 (Batch/Lot number: unknown) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies to Sulfa drug" (unspecified if ongoing). Family history included: "Genetic blood clotting" (unspecified if ongoing). Concomitant medication(s) included: XARELTO. The following information was reported: DYSGEUSIA (non-serious) with onset 23Mar2021 12:40, outcome "unknown", described as "A metallic taste within 10 minutes of the injection"; HEADACHE (non-serious) with onset 23Mar2021 12:45, outcome "unknown", described as "Headache in front of head". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dysgeusia, headache.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was given 0.5 mL of flu vaccine on 8-31-09. On the afternoon of 9-1-09, patient came to me with a red, hot to touch spot on left arm. Area is 3inches wide and 2inches long.  Pt did warm compresses.
This spontaneous report was received from a pharmacist, refers to a 56 year old male patient. The patient's concurrent condition include diabetes and medical history included pneumonia and ex-tobacco user. The patient's past drug history was unknown. On 20-NOV-2015, while the pharmacist was administering the injection, the chamber came apart, and the patient received less than the recommended amount reported as a small amount, possibly none of the 0.5mL of PNEUMOVAX 23 (lot # L008664) intramuscular, (dose was not provided) for prevention. Concomitant therapies were not provided. There was no lab data available. It was reported that the patient continued on PNEUMOVAX 23. Additional information is not expected because the reporter declined to provide additional information.
02apr90 pt vax heptaB. 24hrs later pt devel nausea, dizziness, and a fever 101 F. sx lasted 48hrs and resolved. 09may90 pt vax 2nd hepta B.  pt ex fatigue and recovered.
Red, itchy rash that started around injection site the night of vaccination or morning after and lasted 5 to 7 days.
Initial report received from a health care professional on 26 September 2013. A female patient of unspecified age (birth date reported ad "06"), whose medical history, concomitant medications were not reported and had  no known allergies, had received an intramuscular dose of FLUZONE HD (lot number UH717AA, expiry date: 30 July 2013) in the left deltoid region on 24 September 2013. On 26 September 2013, the patient's arm was red, tender and painful 3 inches below the vaccination site. Laboratory investigations and corrective treatments were not reported. At the time of this report, the patient had not recovered from the events. List of document held by sender: none
Herpes zoster (shingles). Pt treated w/ FAMVIR 50, 1 po TID and given NEURONTIN 100 mg 1 po TID
PT WAS GIVEN THE ADULT DOSE (AGE 12 AND UP). SHE IS 11 YEARS OLD. MOTHER WAS ADVISED 20 MINUTES AFTER THE INJECTION WHEN WE REALIZED WHAT HAD HAPPENED. MOTHER SAID NO PROBLEM BECAUSE HER DAUGHER IS BIG FOR HER AGE. TICKET NUMBER WITH OUR HELP DESK
Tiredness; brain fog; headache; Day 1 Sore arm; This is a spontaneous report from a non-contactable Other Health Professional, the patient. A 59-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, lot number: EK5730), via an unspecified route of administration as a single dose on 30Dec2020 for COVID-19 immunisation. The patient medical history was not reported. No allergies to medications, food, or other products reported. Prior to vaccination, the patient was not diagnosed with COVID 19. Since the vaccination, the patient had not been tested for COVID 19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), calcium/magnesium/ vitamin d nos (CAL MAG), calcium carbonate/colecalciferol/phytomenadione (Vit D+K), fish oil (OMEGA 3) and multivitamins. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Dec2020, the patient experienced sore arm on day 1 of vaccination and on 31Dec2020 experienced tiredness, brain fog and headache. No treatment was received for the events. The outcome of the events were recovered on an unknown date.   No follow-up attempts are possible. No further information is expected.
36 hours following the vaccine I was having a bad headache, moderate to severe pain at injection site, and severe diarrhea.  The diarrhea lasted about 12 hours.  I also felt general discomfort over entire body as if I had flu.  This discomfort lasted for approximately 2 to 3 days.  I was unable to perform normal activities during this time.
Pain at injection site that night. The following morning, gradual numbness in chin and left side of face that felt like novacaine. Numbness also along inner left arm, up to elbow. Headache pain on left side temple and behind ear. Pain in left jaw and what felt like back molar on left side of jaw. Headache and numbness has persisted for two weeks (today is April 28). As of today, numbness also moved to right side of face and arm, along with headache and jaw/molar pain on right side of face. Mouth and lips also numb.
A years' old back injury healed. A years' old shoulder injury healed. My wrinkles have mostly disappeared. I can breathe much better and I can even run again.  My overall health improved DRAMATICALLY after my vaccination.
PT REPORTED GOLD BAL SIZE LUMP TO INJECTION SITE (LD). PT STATED THAT ARM WAS WARM TO TOUCH WITH ISOLATED REDNESS. PT STATED AREA WAS PAINFUL. PT STATED SITE ITCHED AND ITCHING SPREAD TO PT'S FACE AND SCALP. PT WAS ADVISED TO F/U WITH PCP.
Redness around injection site, achy joints, elevated blood sugar beginning 11/28/07.
With the second dose I had chills, body aches and felt light headed. After 24 hours I woke up fine.
Dizziness and sleepiness starting at 10 minutes post injection, lasting 2 hours
p/vax pt noticed itching, heat @ site;area bright red w/purple around the edges;applied ice throughout noc;8 1/2cm length x 4 1/2cm wide;red/purple, warm to touch;
Reaction to COVID booster shot (Phizer):  Low grade fever (Wednesday, Thursday, and Friday), Cough on Wed. Thurs. Fri. Sat., Weakness on W, Th, F, Sa, S and Mon,  Tired (just wanted to sleep), Left arm pain (aching and throbbing starting mid chest, left arm, to left shoulder blade (Wed. evening thru Thursday), Trouble focusing (Th, F, and Sa), Blotchiness on arm around injection sight - developed on Sunday - lasted til Monday  No treatment by doctor given
This spontaneous report was received from a doctor of pharmacy concerning an approximately 76 year old female patient. On 04-JUN-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot number and expiry date reported as J000430 and 10-APR-2014 respectively, dose and route unspecified). No concomitant medications were reported. Approximately on an unknown date in June 2013, the patient developed a red rash about an inch in diameter at the injection site, but the red rash was without pain or itching. The patient sought medical attention (contact pharmacist). No treatment was given. It was unspecified if any lab tests were performed. The patient was not recovered from the events at the time of report. The relatedness for the events was unknown for ZOSTAVAX. Additional information is not expected.